InsidersTradesSigma
Track the 振东制药 stock price and the full directors' dealings record of the company, a publicly traded company based in China. Shares are listed on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 振东制药 has published 2 public disclosures. Market capitalisation: €4.7bn. The latest transaction was reported on 26 January 2026 (Purchase). Among the most active insiders: 雷振宏. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
振东制药 es una empresa centrada en la fabricación de productos farmacéuticos. Cotiza en el mercado XSHE.